ArticleJournal of personalized medicine2026
Factors Facilitating Adoption of Pharmacogenetic Testing by Prescribers of Antidepressants in Four US Health Systems: A Multi-Site Cross-Sectional PGx Implementation Science Study.
Alice B Popejoy, Deborah Cragun, Megan C Roberts, Lisa M Bendz, Sarah Gonzales, Susanne B Haga, R Ryanne Wu, Natasha J Petry, Laura B Ramsey, Ryley Uber and 2 more
Abstract read
In one paragraphArticle in Journal of personalized medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Alice B PopejoyDepartment of Public Health Sciences, UC Davis School of Medicine, University of California at Davis, Davis, CA 95616, USA.ORCID 0000-0003-4976-0628 Deborah CragunDepartment of Community Health Sciences, College of Public Health, University of South Florida, Tampa, FL 33612, USA.
Megan C RobertsEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Lisa M BendzCenter for Medication Policy and Drug Information, Department of Pharmacy, Duke University Hospital, Durham, NC 27710, USA.
Sarah GonzalesDepartment of Population Health Sciences, School of Medicine, Duke University, Durham, NC 27710, USA.
Susanne B HagaCenter for Precision Health, School of Medicine, Duke University, Durham, NC 27710, USA.ORCID 0000-0001-8817-7406 R Ryanne WuDepartment of Medicine, Division of General Internal Medicine, School of Medicine, Duke University, Durham, NC 27710, USA.ORCID 0000-0002-7655-3096 Laura B RamseyDivision of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, MO 64108, USA.ORCID 0000-0001-6417-3961 Ryley UberCenter for Pharmacy Innovation and Outcomes, Geisinger, Danville, PA 17822, USA.
Kaniz MominEshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Nina R SperberDepartment of Population Health Sciences, School of Medicine, Duke University, Durham, NC 27710, USA.ORCID 0000-0001-6640-2510 Funding
Implementing Pharmacogenomics in Diverse Health Care SystemsR21HG011337 · NHGRI · DUKE UNIVERSITY · PI SPERBER, NINA · 2021 to 2021
$455kNHGRI NIH HHS 1R21-HG011337-01A1NHGRI NIH HHS R21 HG011337
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
adoptionantidepressantscoincidence analysis (CNA)diffusion of innovationgenetic testingimplementation sciencepharmacogeneticspsychiatryserotonin and norepinephrine reuptake inhibitors
Identifiers
PMID42645905
PMCPMC13514951
What OpenQuestion holds
Textmetadata
Read underepoch 390